Clonidine tablets
Form: Tablets
Strength: 0.1 mg, 0.2 mg, 0.3 mg
Reference Brands: Catapres(US)
Category: Hypertension
Clonidine tablets, marketed as Catapres or generic in the US and EU, are approved for hypertension, ADHD, and pain management. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical and quality data, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability of clonidine tablets, helping healthcare providers effectively manage hypertension and related conditions worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Antithymocyte Globulin (ATG) powder for injection
Strength: 250mg/5ml
Form: Lyophilized powder
Reference Brands: Thymoglobulin(US & EU)
View Details Get Enquiry
Hydralazine tablets
Strength: 10 mg, 25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Apresoline(US & Eu)
View Details Get Enquiry
Methyldopa tablets
Strength: 250 mg, 500 mg, and 750 mg
Form: Tablets
Reference Brands: Aldomet(US)
View Details Get Enquiry
Clonidine Patch
Strength: 0.1 mg/24 hours, 0.2 mg/24 hours, 0.3 mg/24 hours
Form: transdermal patch
Reference Brands: Catapres(US)
View Details Get Enquiry